Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
Recruiting · NCT07758270 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis. | CNS demyelinating autoimmune disease, Inflammation, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Not stated | 2026-08-11 | NCT07758270 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis | 114 |
| Washington University School of Medicine | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University School of Medicine in St. Louis | St Louis | United States | 31 |